1.35
0.74%
-0.01
アフターアワーズ:
1.41
0.06
+4.44%
前日終値:
$1.36
開ける:
$1.36
24時間の取引高:
1.67M
Relative Volume:
1.14
時価総額:
$395.37M
収益:
$6.23M
当期純損益:
$-95.90M
株価収益率:
-3.4615
EPS:
-0.39
ネットキャッシュフロー:
$-68.47M
1週間 パフォーマンス:
-2.88%
1か月 パフォーマンス:
+20.54%
6か月 パフォーマンス:
-11.18%
1年 パフォーマンス:
-2.17%
Precigen Inc Stock (PGEN) Company Profile
名前
Precigen Inc
セクター
電話
301-556-9900
住所
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
PGEN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
1.35 | 395.37M | 6.23M | -95.90M | -68.47M | -0.39 |
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-03-22 | ダウングレード | JP Morgan | Neutral → Underweight |
2023-05-23 | 開始されました | JP Morgan | Neutral |
2022-11-18 | 開始されました | Cantor Fitzgerald | Overweight |
2021-02-25 | 開始されました | Stifel | Buy |
2021-02-22 | 開始されました | Wells Fargo | Overweight |
2021-02-18 | 開始されました | B. Riley Securities | Buy |
2020-05-08 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Precigen Inc (PGEN) 最新ニュース
Precigen, Inc. (NASDAQ:PGEN) Shares Sold by JPMorgan Chase & Co. - MarketBeat
JPMorgan Chase & Co. Decreases Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World
FY2024 EPS Estimates for Precigen Lifted by HC Wainwright - Defense World
HC Wainwright Has Weak Outlook for Precigen FY2026 Earnings - Defense World
Precigen’s (PGEN) Buy Rating Reiterated at HC Wainwright - Defense World
Investors Purchase High Volume of Call Options on Precigen (NASDAQ:PGEN) - MarketBeat
LexAurum Advisors LLC Raises Stock Holdings in Precigen, Inc. (NASDAQ:PGEN) - MarketBeat
FY2026 EPS Estimates for Precigen Decreased by HC Wainwright - MarketBeat
Precigen (NASDAQ:PGEN) Earns Buy Rating from HC Wainwright - MarketBeat
Precigen Sees Unusually Large Options Volume (NASDAQ:PGEN) - Defense World
Precigen's SWOT analysis: biotech firm's stock poised for growth with PRGN-2012 - MSN
Knight-Swift Transportation Posts Upbeat Earnings, Joins TAL Education, LSI Industries, GE Aerospace And Other Big Stocks Moving Higher On Thursday - Benzinga
Precigen (NASDAQ:PGEN) Given Buy Rating at HC Wainwright - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Stock Position Increased by Barclays PLC - Defense World
Analysts Set Precigen, Inc. (NASDAQ:PGEN) Price Target at $6.33 - Defense World
Precigen, Inc. (NASDAQ:PGEN) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Precigen, Inc. Regains Compliance with Nasdaq Listing Rules - Defense World
Precigen shares rebound above Nasdaq minimum bid price - MSN
Precigen shares rebound above Nasdaq minimum bid price By Investing.com - Investing.com Australia
Should You Invest in Precigen (PGEN)? - MSN
Jane Street Group LLC Reduces Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen's SWOT analysis: gene therapy stock focuses on RRP treatment By Investing.com - Investing.com Australia
Precigen's SWOT analysis: gene therapy stock focuses on RRP treatment - Investing.com India
Precigen's (PGEN) "Market Outperform" Rating Reaffirmed at JMP Securities - MarketBeat
Precigen to Present Plans for Realizing Commercial Vision for PR - GuruFocus.com
Precigen Files BLA for Breakthrough RRP Treatment PRGN-2012, Targets 27,000 US Patients - StockTitan
Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference - StreetInsider.com
Precigen CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Barclays PLC Acquires 124,141 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen, Inc. (NASDAQ:PGEN) Shares Bought by Geode Capital Management LLC - Defense World
PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally? - MSN
Investors Buy Large Volume of Precigen Call Options (NASDAQ:PGEN) - Defense World
Traders Purchase High Volume of Precigen Call Options (NASDAQ:PGEN) - MarketBeat
Exploring 3 Prominent High Growth Tech Stocks In The United States - Simply Wall St
Precigen Completes Regulatory Filing For Approval Of Gene Therapy To Treat Respiratory Papillomatosis: Retail Sentiment Surges Amid Stock Rally - MSN
Precigen, Inc. (NASDAQ:PGEN) Shares Acquired by State Street Corp - Defense World
Precigen Completes Regulatory Filing For Approval Of Gene Therapy To Treat Respiratory Papillomatosis: Retail - Asianet Newsable
Stifel Financial Corp Raises Stock Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen, Inc. announced that it has received $79 million in funding -December 29, 2024 - Marketscreener.com
Precigen’s SWOT analysis: gene therapy firm’s stock faces pivotal year By Investing.com - Investing.com Nigeria
Precigen's SWOT analysis: gene therapy firm's stock faces pivotal year By Investing.com - Investing.com South Africa
Precigen's SWOT analysis: gene therapy firm's stock faces pivotal year - Investing.com
Precigen Inc (PGEN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):